COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,031 Articles (22,627 medRxiv, 8,404 bioRxiv)

Most recent first Previous |  Page 2160: Articles 21591-21600  | Next

A high-throughput microfluidic nano-immunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultra-low volume dried blood samples
Swank, Z., Michielin, G., Yip, H. M., Cohen, P., Andrey, D. O., Vuilleumier, N., Kaiser, L., Eckerle, I., Meyer, B. J., Maerkl, S. J.
10.1101/2020.10.07.20208280 — Posted: 2020-10-09
COVID-19, Type-2 Diabetes, and Associated Health Outcomes in China: Results from a Nationwide Survey of 10,545 Adults
Shi, Z., Yan, A., Zimmet, P., Sun, X., do Vale Moreira, N. C., Cheskin, L. J., Wang, L., Qu, W., Yan, H., Hussain, A., Wang, Y.
10.1101/2020.10.07.20207282 — Posted: 2020-10-09
EFFECT OF CONVALESCENT PLASMA ON MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA
Salazar, M. R., Gonzalez, S. E., Regairaz, L., Ferrando, N. S., Gonzalez, V., Carrera, P. M., Munoz, L., Pesci, S. A., Vidal, J. M., Kreplak, N., Estenssoro, E.
10.1101/2020.10.08.20202606 — Posted: 2020-10-09
Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV2 dynamics
Wodarz, D., Komarova, N. L., Schang, L. M.
10.1101/2020.10.07.20208231 — Posted: 2020-10-09
Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis
Asiimwe, I. G., Pushpakom, S., Turner, R., Kolamunnage-Dona, R., Jorgensen, A., Pirmohamed, M.
10.1101/2020.10.07.20208918 — Posted: 2020-10-09
Report on COVID-19 Verification Case Study in Nine Countries Using the SIQR model
reiji, s.
10.1101/2020.10.07.20208298 — Posted: 2020-10-09
Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities
Hui, B. B., Brown, D., Chisholm, R. H., Geard, N., McVernon, J., Regan, D. G.
10.1101/2020.10.07.20208819 — Posted: 2020-10-09
AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci
Roberts, G. H. L., Park, D. S., Coignet, M. V., McCurdy, S. R., Knight, S. C., Partha, R., Rhead, B., Zhang, M., Berkowitz, N., Science Team, A., Haug Baltzell, A. K., Guturu, H., Girshick, A. R., Rand, K. A., Hong, E. L., Ball, C. A.
10.1101/2020.10.06.20205864 — Posted: 2020-10-09
High seroprevalence of SARS-CoV-2 antibodies among people living in precarious situations in Ile de France
ROEDERER, T., MOLLO, B., VINCENT, C., NIKOLAY, B., LLOSA, A., NESBITT, R., VANHOMWEGEN, J., ROSE, T., ANNA, F., TORRE, C., FOURREY, E., GOYARD, S., JANIN, Y., CHARNEAU, P., VRATSKIKH, O., COURY, A., VANEL, S., MENDIHARAT, P., PORTEN, K., HENNEQUIN, W., MILLS, C., LUQUERO, F.
10.1101/2020.10.07.20207795 — Posted: 2020-10-09 Discussion: Onsite
Isolation of infected people and their contacts is likely to be effective against many short-term epidemics
Geffen, N., Low, M. O.
10.1101/2020.10.07.20207845 — Posted: 2020-10-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).